Progress in Research on Childhood T-cell Acute Lymphocytic Leukemia, Notch1 Signaling Pathway, and Its Inhibitors: A Review

Overview

Journal Bosn J Basic Med Sci

Specialty General Medicine

Date 2020 May 17

PMID 32415821

Citations 5

Authors

Zhong Fang-Fang

Yang You

Liu Wen-Jun

Affiliations

Soon will be listed here.

Abstract

Childhood leukemia is cancer that seriously threatens the life of children in China. Poor sensitivity to chemotherapy and susceptibility to drug resistance are the reasons for the treatment of T-cell acute lymphocytic leukemia (T-ALL) being extremely difficult. Moreover, traditional intensive chemotherapy regimens cause great damage to children. Therefore, it is highly important to search for targeted drugs and develop a precise individualized treatment for child patients. There are activating mutations in the NOTCH1 gene in more than 50% of human T-ALLs and the Notch signaling pathway is involved in the pathogenesis of T-ALL. In this review, we summarize the progress in research on T-ALL and Notch1 signaling pathway inhibitors to provide a theoretical basis for the clinical treatment of T-ALL.

Citing Articles

Cannabinoid combination targets -mutated T-cell acute lymphoblastic leukemia through the integrated stress response pathway.

Besser E, Gelfand A, Procaccia S, Berman P, Meiri D Elife. 2024; 12.

PMID: 39258755 PMC: 11390110. DOI: 10.7554/eLife.90854.

Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.

Huang Y, Wan C, Dai H, Xue S Ann Hematol. 2023; 102(8):2001-2013.

PMID: 37227492 DOI: 10.1007/s00277-023-05286-3.

External Evaluation of Population Pharmacokinetic Models of Methotrexate for Model-Informed Precision Dosing in Pediatric Patients with Acute Lymphoid Leukemia.

Wang S, Yin Q, Yang M, Cheng Z, Xie F Pharmaceutics. 2023; 15(2).

PMID: 36839891 PMC: 9962320. DOI: 10.3390/pharmaceutics15020569.

Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review.

Gao L, Lu J, Li J, Hu Y, Lu Y, Du W Int J Hematol. 2022; 117(5):781-785.

PMID: 36472792 DOI: 10.1007/s12185-022-03504-8.

Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia.

Zheng R, Li M, Wang S, Liu Y Exp Hematol Oncol. 2020; 9(1):31.

PMID: 33292596 PMC: 7664086. DOI: 10.1186/s40164-020-00187-x.

References

Girardi T, Vicente C, Cools J, De Keersmaecker K . The genetics and molecular biology of T-ALL. Blood. 2017; 129(9):1113-1123. PMC: 5363819. DOI: 10.1182/blood-2016-10-706465. View

Agnusdei V, Minuzzo S, Frasson C, Grassi A, Axelrod F, Satyal S . Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts. Leukemia. 2013; 28(2):278-88. DOI: 10.1038/leu.2013.183. View

Papadantonakis N, Advani A . Recent advances and novel treatment paradigms in acute lymphocytic leukemia. Ther Adv Hematol. 2016; 7(5):252-269. PMC: 5026289. DOI: 10.1177/2040620716652289. View

Matloub Y, Stork L, Asselin B, Hunger S, Borowitz M, Jones T . Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia--Comparison among Different Treatment Strategies. Pediatr Blood Cancer. 2015; 63(2):255-61. PMC: 4715507. DOI: 10.1002/pbc.25793. View

Hounjet J, Habets R, Schaaf M, Hendrickx T, Barbeau L, Yahyanejad S . The anti-malarial drug chloroquine sensitizes oncogenic NOTCH1 driven human T-ALL to γ-secretase inhibition. Oncogene. 2019; 38(27):5457-5468. DOI: 10.1038/s41388-019-0802-x. View

Asnafi V, Buzyn A, Le Noir S, Baleydier F, Simon A, Beldjord K . NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood. 2008; 113(17):3918-24. DOI: 10.1182/blood-2008-10-184069. View

Yeh C, Bellon M, Pancewicz-Wojtkiewicz J, Nicot C . Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients. Proc Natl Acad Sci U S A. 2016; 113(24):6731-6. PMC: 4914202. DOI: 10.1073/pnas.1601537113. View

Sanchez-Martin M, Ambesi-Impiombato A, Qin Y, Herranz D, Bansal M, Girardi T . Synergistic antileukemic therapies in -induced T-ALL. Proc Natl Acad Sci U S A. 2017; 114(8):2006-2011. PMC: 5338362. DOI: 10.1073/pnas.1611831114. View

Gao C, Liu S, Zhang R, Li W, Zhao X, Cui L . NOTCH1 mutations are associated with favourable long-term prognosis in paediatric T-cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH-2003 and CCLG-2008 protocol in China. Br J Haematol. 2014; 166(2):221-8. DOI: 10.1111/bjh.12866. View

10.

Gusscott S, Jenkins C, Lam S, Giambra V, Pollak M, Weng A . IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias. PLoS One. 2016; 11(8):e0161158. PMC: 4988785. DOI: 10.1371/journal.pone.0161158. View

11.

Roti G, Stegmaier K . New Approaches to Target T-ALL. Front Oncol. 2014; 4:170. PMC: 4085879. DOI: 10.3389/fonc.2014.00170. View

12.

Clappier E, Collette S, Grardel N, Girard S, Suarez L, Brunie G . NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia. 2010; 24(12):2023-31. DOI: 10.1038/leu.2010.205. View

13.

Wu W, Nie L, Zhang L, Li Y . The notch pathway promotes NF-κB activation through Asb2 in T cell acute lymphoblastic leukemia cells. Cell Mol Biol Lett. 2018; 23:37. PMC: 6085606. DOI: 10.1186/s11658-018-0102-4. View

14.

Tzoneva G, Ferrando A . Recent advances on NOTCH signaling in T-ALL. Curr Top Microbiol Immunol. 2012; 360:163-82. DOI: 10.1007/82_2012_232. View

15.

Weng A, Ferrando A, Lee W, Morris 4th J, Silverman L, Sanchez-Irizarry C . Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004; 306(5694):269-71. DOI: 10.1126/science.1102160. View

16.

Ferrandino F, Grazioli P, Bellavia D, Campese A, Screpanti I, Felli M . Notch and NF-κB: Coach and Players of Regulatory T-Cell Response in Cancer. Front Immunol. 2018; 9:2165. PMC: 6193072. DOI: 10.3389/fimmu.2018.02165. View

17.

Oliveira M, Akkapeddi P, Ribeiro D, Melao A, Barata J . IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update. Adv Biol Regul. 2018; 71:88-96. PMC: 6386770. DOI: 10.1016/j.jbior.2018.09.012. View

18.

Wang H, Guo Q, Yang P, Long G . Restoration of microRNA-212 causes a G0/G1 cell cycle arrest and apoptosis in adult T-cell leukemia/lymphoma cells by repressing CCND3 expression. J Investig Med. 2016; 65(1):82-87. DOI: 10.1136/jim-2016-000233. View

19.

Tetik Vardarli A, Duzgun Z, Erdem C, Tezcanli Kaymaz B, Eroglu Z, Cetintas V . Matrine induced G0/G1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia (T-ALL) cells. Bosn J Basic Med Sci. 2017; 18(2):141-149. PMC: 5988533. DOI: 10.17305/bjbms.2017.2457. View

20.

Medyouf H, Gusscott S, Wang H, Tseng J, Wai C, Nemirovsky O . High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling. J Exp Med. 2011; 208(9):1809-22. PMC: 3171095. DOI: 10.1084/jem.20110121. View